SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-004067
Filing Date
2024-04-02
Accepted
2024-04-01 21:22:13
Documents
177
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F fsd_20f.htm   iXBRL 20-F 3272101
2 AMENDED AND RESTATED BY-LAW NUMBER AND BYLAW fsd_ex12.htm EX-1.2 119056
3 DESCRIPTION OF SECURITIES fsd_ex21.htm EX-2.1 31666
4 ARRANGEMENT AGREEMENT fsd_ex42.htm EX-4.2 281601
5 EXCLUSIVE INTELLECTUAL PROPERTY LICENSE AGREEMENT fsd_ex43.htm EX-4.3 272437
6 WARRANT CERTIFICATE fsd_ex44.htm EX-4.4 109779
7 LOAN AGREEMENT AND SECURITY AGREEMENT fsd_ex45.htm EX-4.5 237185
8 LIST OF SUBSIDIARIES fsd_ex81.htm EX-8.1 3934
9 CERTIFICATION fsd_ex121.htm EX-12.1 7867
10 CERTIFICATION fsd_ex122.htm EX-12.2 7848
11 CERTIFICATION fsd_ex131.htm EX-13.1 3903
12 CERTIFICATION fsd_ex132.htm EX-13.2 4413
13 MANAGEMENTS DISCUSSION AND ANALYSIS fsd_ex151.htm EX-15.1 169206
14 CONSENT OF INDEPENDENT AUDITOR fsd_ex152.htm EX-15.2 5102
15 CLAWBACK POLICY fsd_ex971.htm EX-97.1 46921
21 fsd_ex151img92.jpg GRAPHIC 15248
22 fsd_ex151img72.jpg GRAPHIC 10711
23 fsd_ex151img71.jpg GRAPHIC 10716
24 fsd_ex151img70.jpg GRAPHIC 11072
25 fsd_ex151img69.jpg GRAPHIC 10660
26 fsd_ex151img68.jpg GRAPHIC 24036
27 fsd_ex151img67.jpg GRAPHIC 10809
28 fsd_ex151img66.jpg GRAPHIC 43031
29 fsd_ex151img65.jpg GRAPHIC 59620
30 fsd_ex151img64.jpg GRAPHIC 21256
31 fsd_ex151img63.jpg GRAPHIC 9298
32 fsd_ex151img62.jpg GRAPHIC 10281
33 fsd_ex151img61.jpg GRAPHIC 9971
34 fsd_ex151img60.jpg GRAPHIC 10650
35 fsd_ex151img59.jpg GRAPHIC 10302
36 fsd_ex151img58.jpg GRAPHIC 9334
37 fsd_ex151img57.jpg GRAPHIC 9707
38 fsd_ex151img73.jpg GRAPHIC 11193
39 fsd_ex151img74.jpg GRAPHIC 11727
40 fsd_ex151img91.jpg GRAPHIC 21846
41 fsd_ex151img90.jpg GRAPHIC 143903
42 fsd_ex151img89.jpg GRAPHIC 120161
43 fsd_ex151img88.jpg GRAPHIC 45074
44 fsd_ex151img87.jpg GRAPHIC 39127
45 fsd_ex151img86.jpg GRAPHIC 39041
46 fsd_ex151img85.jpg GRAPHIC 15270
47 fsd_ex151img84.jpg GRAPHIC 14283
48 fsd_ex151img82.jpg GRAPHIC 15964
49 fsd_ex151img81.jpg GRAPHIC 16042
50 fsd_ex151img80.jpg GRAPHIC 23602
51 fsd_ex151img79.jpg GRAPHIC 19272
52 fsd_ex151img78.jpg GRAPHIC 30438
53 fsd_ex151img77.jpg GRAPHIC 24620
54 fsd_ex151img76.jpg GRAPHIC 11190
55 fsd_ex151img75.jpg GRAPHIC 11056
56 fsd_ex151img56.jpg GRAPHIC 10124
57 fsd_ex151img55.jpg GRAPHIC 9691
58 fsd_ex151img54.jpg GRAPHIC 18778
59 fsd_ex151img83.jpg GRAPHIC 128396
60 fsd_20fimg10.jpg GRAPHIC 3656
61 fsd_20fimg11.jpg GRAPHIC 2355
62 fsd_20fimg12.jpg GRAPHIC 1916
63 fsd_20fimg2.jpg GRAPHIC 25277
64 fsd_ex152img1.jpg GRAPHIC 3121
65 fsd_ex152img2.jpg GRAPHIC 2101
66 fsd_ex152img4.jpg GRAPHIC 1724
67 fsd_ex151img47.jpg GRAPHIC 16066
68 fsd_ex151img53.jpg GRAPHIC 9791
69 fsd_20fimg13.jpg GRAPHIC 18221
70 fsd_ex151img52.jpg GRAPHIC 33343
71 fsd_ex151img51.jpg GRAPHIC 73968
72 fsd_ex151img50.jpg GRAPHIC 47015
73 fsd_ex151img49.jpg GRAPHIC 49527
74 fsd_ex151img48.jpg GRAPHIC 13893
  Complete submission text file 0001654954-24-004067.txt   15838099

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA fsd-20231231.xsd EX-101.SCH 141615
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE fsd-20231231_lab.xml EX-101.LAB 561985
18 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fsd-20231231_cal.xml EX-101.CAL 74361
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fsd-20231231_pre.xml EX-101.PRE 461822
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fsd-20231231_def.xml EX-101.DEF 289202
181 EXTRACTED XBRL INSTANCE DOCUMENT fsd_20f_htm.xml XML 2682222
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-39152 | Film No.: 24811995
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)